Achaogen

AKAOQ OTCMKTS
0.0100
-0.0030
-23.08%
已收盘, 16:00 08/16 EDT
开盘
0.0105
昨收
0.0130
最高
0.0139
最低
0.0100
成交量
1.60万
成交均量(3M)
389.13万
52周最高
5.95
52周最低
0.0080
换手率
0.03%
市值
63.88万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Achaogen AKAOQ股票价格,Achaogen股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Achaogen, Inc. is a late-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. The Company is involved in researching and developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae (CRE). Plazomicin is an intravenous aminoglycoside antibiotic. The Company has developed plazomicin by chemically modifying sisomicin, a naturally occurring aminoglycoside, in order to overcome common aminoglycoside resistance mechanisms. The Company has a portfolio of small molecule and antibody programs. The Company's Early Development programs include C-Scape and LpxC.
展开 >

最近浏览

名称
价格
涨跌幅